Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Uncontrolled hypertension is associated with coronary artery calcification and electrocardiographic left ventricular hypertrophy: a case-control study

Subjects

Abstract

We conducted a 1:2 matched case-control study in order to evaluate whether the prevalence of coronary artery calcium (CAC) and electrocardiographic left ventricular hypertrophy (LVH) or strain was higher in patients with uncontrolled hypertension than in subjects from the general population, and evaluate the association between CAC and LVH in patients with uncontrolled hypertension. Cases were patients with uncontrolled hypertension, whereas the controls were random individuals from the general population without cardiovascular disease. CAC score was assessed using a non-contrast computed tomographic scan. LVH was evaluated using the Sokolow–Lyon voltage combination and Cornell voltage-duration product, respectively. Associations between CAC, LVH and traditional cardiovascular risk factors were tested by means of ordinal, conditional and classic binary logistic regression models. We found that uncontrolled hypertension was independently associated with both an ordinal CAC score category (odds ratio (OR) 3.9 (95% CI, 1.6–9.1), P=0.002), the presence of CAC score>99 (OR 4.5 (95% CI, 1.4–14.7), P=0.01) and electrocardiographic LVH (OR 10.1 (95% CI, 3.4–30.2), P<0.001) on both univariate and multivariable analyses. There was, however, no correlation between CAC and LVH. The lack of an association between CAC and LVH suggests that they are markers of different complications of hypertension and may have independent predictive values. Patients with both CAC and LVH may be at higher risk than those in whom only one of these markers is present.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33 (13): 1635–1701.

    Article  CAS  Google Scholar 

  2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24 (11): 987–1003.

    Article  CAS  Google Scholar 

  3. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB . Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97 (18): 1837–1847.

    Article  CAS  Google Scholar 

  4. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56 (17): 1397–1406.

    Article  Google Scholar 

  5. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006; 114 (16): 1761–1791.

    Article  Google Scholar 

  6. Erbel R, Lehmann N, Möhlenkamp S, Churzidse S, Bauer M, Kälsch H et al. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension 2012; 59 (1): 44–53.

    Article  CAS  Google Scholar 

  7. Bonow RO . Clinical practice. Should coronary calcium screening be used in cardiovascular prevention strategies? New Engl J Med 2009; 361 (10): 990–997.

    Article  CAS  Google Scholar 

  8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34 (28): 2159–2219.

    Article  Google Scholar 

  9. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB . Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90 (4): 1786–1793.

    Article  CAS  Google Scholar 

  10. Diederichsen SZ, Gerke O, Olsen MH, Lambrechtsen J, Sand NP, Nørgaard BL et al. Coronary artery calcification and ECG pattern of left ventricular hypertrophy or strain identify different healthy individuals at risk. J Hypertens 2013; 31 (3): 595–600.

    Article  CAS  Google Scholar 

  11. Diederichsen AC, Sand NP, Nørgaard B, Lambrechtsen J, Jensen JM, Munkholm H et al. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 2012; 19 (3): 558–564.

    Article  Google Scholar 

  12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R . Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15 (4): 827–832.

    Article  CAS  Google Scholar 

  13. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ . Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003; 228 (3): 826–833.

    Article  Google Scholar 

  14. Pletcher MJ, Tice JA, Pignone M, Browner WS . Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004; 164 (12): 1285–1292.

    Article  Google Scholar 

  15. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007; 115 (3): 402–426.

    Article  Google Scholar 

  16. Sokolow M, Lyon TP . The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37 (2): 161–186.

    Article  CAS  Google Scholar 

  17. Molloy TJ, Okin PM, Devereux RB, Kligfield P . Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20 (5): 1180–1186.

    Article  CAS  Google Scholar 

  18. Okin PM, Roman MJ, Devereux RB, Kligfield P . Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25 (2): 417–423.

    Article  CAS  Google Scholar 

  19. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S . The electrocardiogram in population studies. A classification system. Circulation 1960; 21: 1160–1175.

    Article  CAS  Google Scholar 

  20. Williams RL . A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56 (2): 645–646.

    Article  CAS  Google Scholar 

  21. Allen NB, Siddique J, Wilkins JT, Shay C, Lewis CE, Goff DC et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA 2014; 311 (5): 490–497.

    Article  CAS  Google Scholar 

  22. Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E . Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population. Blood Press 2008; 17 (2): 110–115.

    Article  Google Scholar 

  23. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Engl J Med 2008; 358 (13): 1336–1345.

    Article  CAS  Google Scholar 

  24. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303 (16): 1610–1616.

    Article  CAS  Google Scholar 

  25. Miedema MD, Duprez DA, Misialek JR, Blaha MJ, Nasir K, Silverman MG et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes 2014; 7 (3): 453–460.

    Article  Google Scholar 

  26. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361 (9364): 1149–1158.

    Article  CAS  Google Scholar 

  27. Norman JE Jr, Levy D . Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol 1995; 26 (4): 1022–1029.

    Article  Google Scholar 

  28. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P . Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987; 75 (3): 565–572.

    Article  CAS  Google Scholar 

  29. Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998; 32 (6): 989–997.

    Article  Google Scholar 

  30. Chou R, Arora B, Dana T, Fu R, Walker M, Humphrey L . Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155 (6): 375–385.

    Article  Google Scholar 

  31. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ et al. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 2004; 44 (4): 459–464.

    Article  CAS  Google Scholar 

  32. Auer R, Bauer DC, Marques-Vidal P, Butler J, Min LJ, Cornuz J et al. Association of major and minor ECG abnormalities with coronary heart disease events. J Am Med Assoc 2012; 307 (14): 1497–1505.

    Article  CAS  Google Scholar 

  33. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. J Am Med Assoc 2004; 292 (19): 2343–2349.

    Article  CAS  Google Scholar 

  34. Falaschetti E, Mindell J, Knott C, Poulter N . Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 2014; 383 (9932): 1912–1919.

    Article  Google Scholar 

  35. Myers MG . Eliminating the human factor in office blood pressure measurement. J Clin Hypertens (Greenwich) 2014; 16 (7): 541–542.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M L Nielsen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nielsen, M., Pareek, M., Gerke, O. et al. Uncontrolled hypertension is associated with coronary artery calcification and electrocardiographic left ventricular hypertrophy: a case-control study. J Hum Hypertens 29, 303–308 (2015). https://doi.org/10.1038/jhh.2014.88

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.88

This article is cited by

Search

Quick links